Samumed
SA
SA

Samumed

DR41Ahrefs DR: 41/100. Below median. Measured by Ahrefs. Median 44.Agent21Agent Readiness: 21/100. Bottom 25%. Measured by StartupHub.ai. Median 41.Speed77Site Speed: 77/100. Top 25%. Measured by Google PageSpeed. Median 62.

Biotech company developing novel therapeutics for regenerative medicine and oncology.

Website
1997ActiveSan Diego, United States

About

Samumed is a private, clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule drugs that activate the Wnt/beta-catenin pathway. Their research targets a wide range of diseases, including degenerative conditions, oncology, and fibrosis.

Key facts

At-a-glance profile data

Website
biosplice.com
Headquarters
San Diego, United States
Founded
1997
Total funding
-
Business model
B2B

Tech stack

Detected on biosplice.com, last scanned 11 Aug 2026. Run your own scan

Frontend
Tailwind CSS, Bootstrap
Analytics
Google Analytics 4, Segment
Email provider
Microsoft 365
Add first review